Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Other Investing Activities (as filed) (2011 - 2019)

Updated

Grace Therapeutics' Other Investing Activities (as filed) came in at $46,965 for fiscal Q3 2020 (quarter ended Dec 31, 2019), down 26.2% from $63,640 a year earlier and down 55.1% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Other Investing Activities (as filed) (2011 - 2019) Analysis & Trends

Over the trailing twelve months to Dec 31, 2019, Grace Therapeutics reported Other Investing Activities (as filed) of $420,086, up 180.9% year-over-year; for FY2019 (ended Mar 31, 2019), it was $292,804, up 436.5% from FY2018.

  • Other Investing Activities (as filed) carries a five-year compound annual growth rate of 24.4% (FY2014 to FY2019).
  • Going back by fiscal year, Other Investing Activities (as filed) was $54,580 in FY2018, $111,344 in FY2017 (+27.3%), $87,475 in FY2016 (+113.4%) and $41,000 in FY2015 (-58.2%).
  • The fiscal Q3 2020 figure represents the lowest quarterly Other Investing Activities (as filed) since fiscal Q1 2019.
  • Year-over-year, Other Investing Activities (as filed) increased in six of the last seven quarters, with growth averaging 355.5%.
  • The fastest year-over-year change in Other Investing Activities (as filed) over five years came in fiscal Q3 2019 (growth of 798.3%), and the weakest in fiscal Q1 2016 (a decline of 42.3%).
  • Business Quant data shows GRCE's Other Investing Activities (as filed) at $104,553 (Q2 2020), $103,141 (Q1 2020) and $165,427 (Q4 2019) in the three fiscal quarters before Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (as filed) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 86.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 352.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 946.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -54.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -3.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -60.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -62.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 14.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 79.00 Mn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 46,964.90
Sep 30, 2019 104,552.72
Jun 30, 2019 103,141.39
Mar 31, 2019 165,426.65
Dec 31, 2018 63,640.06
Sep 30, 2018 48,193.15
Jun 30, 2018 13,177.70
Mar 31, 2018 24,527.33
Dec 31, 2017 7,084.28
Sep 30, 2017 11,163.69
Jun 30, 2017 11,899.46
Nov 30, 2016 70,215.74
Aug 31, 2016 8,478.76
May 31, 2016 12,000.00
Nov 30, 2015 935.00
Aug 31, 2015 80,412.00
May 31, 2015 11,888.00
Feb 28, 2015 9,821.00
Nov 30, 2014 304.00
Aug 31, 2014 10,287.00
API Access

Grace Therapeutics Other Investing Activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=GRCE&period=max&api_key=YOUR_API_KEY